Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recommended
How to apply for FEMA assistance after Helene
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
1.720
-0.040 (-2.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
467,589
Open
1.770
Bid (Size)
1.710 (10)
Ask (Size)
1.770 (32)
Prev. Close
1.760
Today's Range
1.670 - 1.780
52wk Range
1.420 - 2.500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
aTyr Pharma to Participate in September Investor Conferences
August 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2024
August 13, 2024
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-5.49%
-5.49%
1 Month
-3.37%
-3.37%
3 Month
+10.26%
+10.26%
6 Month
-5.49%
-5.49%
1 Year
-5.49%
-5.49%
More News
Read More
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 13, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
July 25, 2024
Via
Benzinga
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
July 22, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2023
June 10, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.